A honey energy product is being recalled for containing an undeclared ingredient used for erectile dysfunction treatment.

The Food and Drug Administration recalled a honey energy supplement on Wednesday after an undeclared erectile dysfunction ...

Vybrique is an oral film formulation of sildenafil, a phosphodiesterate-5 inhibitor, designed to dissolve on the tongue without the need for food or water.

FDA has approved Vybrique, the first oral film formulation of sildenafil for the treatment of erectile dysfunction, offering ...

In today’s Pharmaceutical Executive Daily, FDA approves Vybrique for erectile dysfunction, experts argue Phase III clinical ...

The FDA issued a recall Wednesday for a honey energy supplement after an undeclared erectile dysfunction medication was found ...

ED is characterized by the inability to achieve or maintain an erection sufficient for sexual activity. It can be caused by various factors, including physical conditions such as cardiovascular ...

IBSA USA, the U.S. subsidiary of the Swiss pharmaceutical company IBSA, announced today that the Food and Drug Administration ...

There are four main causes of ED: psychogenic, vascular, hormonal and neurologic.

An experimental therapy known as low-intensity shock wave treatment might improve erectile dysfunction, particularly for men with only mild to moderate sexual difficulties, a research review suggests.

In some people with kidney stones, low-intensity shockwave therapy (LIST) breaks them up. And in some with heart disease and fractures, LIST coaxes the body to produce new blood vessels that help with ...

You don’t need to take it with water.